MedTrace Logo

Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis

NCT03527680 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2018-05-17

No results posted yet for this study

Summary

Uremic toxins such as p-cresol and phenol are suggested to be associated with higher mortality in hemodialysis patients. The aim of this study was to investigate the effects of probiotics on serum p-cresol level in hemodialysis patients.

Conditions

  • Hemodialysis Complication

Interventions

DIETARY_SUPPLEMENT

Lactobacillus rhamnosus

daily one capsule containing 1.6\*107 CFU of Lactobacillus Rhamnosus prepared by Tabriz Nutrition Research Center from yogurt and cheese of different farms located in the suburbs Heris, after meal for 28 days

DRUG

Placebo - Cap

daily one capsule of placebo

Sponsors & Collaborators

  • nooshin dalili

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-01
Primary Completion
2016-11-30
Completion
2016-12-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03527680 on ClinicalTrials.gov